Marathon Petroleum Corporation · MPC · FY2025 Q4 · Calendar Q1 2026
Marathon Petroleum: record 2025, 105% capture, 49.6% EPS beat
Marathon Petroleum enters 2026 from a record year: 105% margin capture, record midstream EBITDA near $7B and $8.3B of operating cash flow. Management is prioritizing capital discipline and cash return, cutting refining capex 20% to $700M while planning a similar $4.5B shareholder return. The thesis of durable cash generation rests on a tight global refining system and structural demand growth for gasoline, distillates and jet fuel, plus MPLX's $2.4B growth program expected to deliver mid-teens returns and over $3.5B in distributions to MPC. The Q4 print reinforced the bullish case with a 49.6% EPS beat and a 6.0% same-session market move, though the high captured-margin backdrop is a level that bears watching for normalization.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about MPC FY2025 Q4
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Marathon Petroleum closed out FY2025 with record results, reporting Q4 EPS of $4.07 versus the $2.72 consensus (a 49.6% surprise) and revenue of $33.42B versus $31.08B expected. The stock rose 6.03% in the event session versus a 0.85% decline in the benchmark, with volume roughly 2.2x baseline and a 17.7% subsequent drift. Management raised the profile of capital discipline, cutting 2026 refining capex 20% to $700M, and reiterated a target of repaying roughly $4.5B to shareholders in 2026.
Guidance delta
Maintained. Management expects to repeat a roughly $4.5B shareholder return in 2026, with refining capex cut 20% year over year to $700M and capital discipline targeting 25%-plus returns.
Key takeaways
- Q4 EPS of $4.07 came in 49.6% above the $2.72 consensus, with revenue of $33.42B topping the $31.08B estimate by 7.5%.
- 2025 was a record year, with 105% margin capture, record midstream EBITDA near $7B and $8.3B cash from operations.
- Refining capex is being cut 20% YoY to $700M for 2026, focused on high-return projects at Garyville, Robinson, Galveston Bay and El Paso.
- Management expects demand for refined products to outpace capacity additions through the decade and plans a similar $4.5B shareholder return in 2026.
- MPLX is allocating $2.4B to Permian and Marcellus growth projects, and expects over $3.5B in cash distributions to MPC.
Management priorities
- Cut 2026 refining capex 20% to $700M and keep returns above 25% on investment.
- Commission the El Paso refinery upgrade in Q2 2026 to expand higher-value product capacity.
- Complete Garyville feedstock optimization and export gasoline projects, with startups targeted at end-2027.
- Grow the branded station network with continued $250M marketing spend.
- Return about $4.5B to shareholders in 2026 through dividends and buybacks.
Follow MPC with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 25, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Jefferies | Hold | Buy | Downgrade | Sep 22, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Sep 21, 2026 |
| Raymond James | Outperform | Outperform | Maintain | Sep 14, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Sep 14, 2026 |
| UBS | Buy | Buy | Maintain | Sep 8, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Sep 3, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Sep 1, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Aug 11, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 6, 2026 |
| TD Cowen | Buy | Buy | Maintain | Aug 5, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Aug 5, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 5, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Apr 22, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Feb 9, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Sep 3, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jul 14, 2025 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 9, 2024 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 2, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 1, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | May 4, 2022 |
| Macquarie | Outperform | Outperform | Maintain | Feb 6, 2019 |
| Standpoint Research | Buy | Accumulate | Maintain | Dec 26, 2018 |
| Bank of America | Buy | Neutral | Upgrade | May 10, 2018 |
| Deutsche Bank | Buy | Buy | Maintain | Mar 19, 2018 |
| PiperJaffray | Neutral | Neutral | Maintain | Sep 16, 2016 |
| Scotia Howard Weil | Sector Outperform | Sector Perform | Upgrade | Dec 15, 2015 |
| Oppenheimer | Outperform | Perform | Upgrade | May 27, 2015 |
| S&P Capital IQ | Buy | Hold | Upgrade | Jul 3, 2014 |
| Imperial Capital | Outperform | In Line | Upgrade | Jan 31, 2014 |
| ISI Group | Buy | Neutral | Upgrade | Jan 30, 2014 |
| Simmons & Co. | Overweight | Neutral | Upgrade | Dec 2, 2013 |
| Tudor Pickering | Buy | Buy | Maintain | Jul 23, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $389.68. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Jefferies | Lloyd Byrne | $413 | $402.38 | +6.0% | Sep 21, 2026 |
| Goldman Sachs | Analyst unavailable | $472 | $424.89 | +21.1% | Sep 21, 2026 |
| Raymond James | Analyst unavailable | $445 | $404.77 | +14.2% | Sep 14, 2026 |
| Morgan Stanley | Joe Laetsch | $453 | $407.14 | +16.2% | Sep 14, 2026 |
| UBS | Analyst unavailable | $450 | $388.9 | +15.5% | Sep 8, 2026 |
| Piper Sandler | John Royall | $462 | $387 | +18.6% | Sep 3, 2026 |
| Wells Fargo | Analyst unavailable | $400 | $373.32 | +2.6% | Sep 1, 2026 |
| Mizuho Securities | Analyst unavailable | $304 | $320.32 | -22.0% | Aug 11, 2026 |
| Piper Sandler | John Royall | $344 | $300.09 | -11.7% | Aug 6, 2026 |
| Barclays | Analyst unavailable | $321 | $297.75 | -17.6% | Aug 6, 2026 |
| Evercore ISI | Analyst unavailable | $330 | $310.71 | -15.3% | Aug 5, 2026 |
| Wells Fargo | Analyst unavailable | $359 | $312.61 | -7.9% | Aug 5, 2026 |
| Piper Sandler | Analyst unavailable | $343 | $315.82 | -12.0% | Jul 23, 2026 |
| Raymond James | Justin Jenkins | $335 | $294.06 | -14.0% | Jul 13, 2026 |
| Barclays | Analyst unavailable | $289 | $283.74 | -25.8% | Jul 13, 2026 |
| Jefferies | Analyst unavailable | $335 | $283.74 | -14.0% | Jul 12, 2026 |
| UBS | Manav Gupta | $321 | $280.61 | -17.6% | Jul 10, 2026 |
| Wells Fargo | Sam Margolin | $344 | $263.58 | -11.7% | Jun 15, 2026 |
| Morgan Stanley | Analyst unavailable | $265 | $260.81 | -32.0% | Jun 12, 2026 |
| Mizuho Securities | Analyst unavailable | $284 | $248.05 | -27.1% | May 27, 2026 |
| UBS | Analyst unavailable | $285 | $249.32 | -26.9% | May 6, 2026 |
| Barclays | Analyst unavailable | $270 | $260.51 | -30.7% | May 6, 2026 |
| Morgan Stanley | Joe Laetsch | $233 | $221.1 | -40.2% | Apr 24, 2026 |
| Barclays | Analyst unavailable | $230 | $220.27 | -41.0% | Apr 10, 2026 |
| Piper Sandler | Analyst unavailable | $228 | $223.52 | -41.5% | Apr 9, 2026 |
| BMO Capital | Phillip Jungwirth | $225 | $203.91 | -42.3% | Feb 9, 2026 |
| UBS | Manav Gupta | $221 | $203.63 | -43.3% | Feb 6, 2026 |
| Wells Fargo | Analyst unavailable | $217 | $187.58 | -44.3% | Feb 4, 2026 |
| Scotiabank | Paul Cheng | $174 | $176.1 | -55.3% | Jan 16, 2026 |
| Mizuho Securities | Analyst unavailable | $205 | $175.54 | -47.4% | Jan 13, 2026 |
| Piper Sandler | Analyst unavailable | $184 | $172.51 | -52.8% | Jan 8, 2026 |
| Mizuho Securities | Analyst unavailable | $196 | $186.97 | -49.7% | Dec 12, 2025 |
| Raymond James | Justin Jenkins | $200 | $184.54 | -48.7% | Nov 4, 2025 |
| Raymond James | Justin Jenkins | $203 | $181.15 | -47.9% | Oct 17, 2025 |
| Barclays | Theresa Chen | $194 | $180.89 | -50.2% | Oct 13, 2025 |
| Scotiabank | Analyst unavailable | $189 | $189.06 | -51.5% | Oct 9, 2025 |
| Morgan Stanley | Analyst unavailable | $200 | $192.24 | -48.7% | Oct 3, 2025 |
| UBS | Analyst unavailable | $220 | $196.44 | -43.5% | Sep 26, 2025 |
| Evercore ISI | Stephen Richardson | $170 | $167.42 | -56.4% | Jun 18, 2025 |
| Raymond James | Analyst unavailable | $193 | $147.35 | -50.5% | Mar 27, 2025 |
| Barclays | Analyst unavailable | $161 | $141.15 | -58.7% | Mar 14, 2025 |
| Morgan Stanley | Joe Laetsch | $174 | $151.06 | -55.3% | Dec 19, 2024 |
| Bank of America Securities | Jean Ann Salisbury | $174 | $157.9 | -55.3% | Oct 17, 2024 |
| Scotiabank | Paul Cheng | $170 | $162.61 | -56.4% | Oct 10, 2024 |
| Piper Sandler | Ryan Todd | $145 | $164.22 | -62.8% | Sep 24, 2024 |
| UBS | Manav Gupta | $189 | $163.58 | -51.5% | Sep 14, 2024 |
| Wolfe Research | Doug Leggate | $200 | $165.56 | -48.7% | Jul 17, 2024 |
| Jefferies | Lloyd Byrne | $231 | $165.46 | -40.7% | Jul 14, 2024 |
| Wells Fargo | Roger Read | $196 | $164.29 | -49.7% | Jul 12, 2024 |
| Mizuho Securities | Nitin Kumar | $201 | $172.45 | -48.4% | Jun 20, 2024 |
| Piper Sandler | Ryan Todd | $168 | $168.9 | -56.9% | Jun 14, 2024 |
| Raymond James | Justin Jenkins | $230 | $174.66 | -41.0% | May 30, 2024 |
| Piper Sandler | Ryan Todd | $190 | $177.86 | -51.2% | May 14, 2024 |
| Mizuho Securities | Nitin Kumar | $203 | $179.56 | -47.9% | May 13, 2024 |
| Barclays | Theresa Chen | $195 | $182.55 | -50.0% | May 6, 2024 |
| Mizuho Securities | Nitin Kumar | $202 | $212.27 | -48.2% | Apr 12, 2024 |
| Piper Sandler | Ryan Todd | $204 | $216.25 | -47.6% | Apr 5, 2024 |
| Wells Fargo | Roger Read | $227 | $214.96 | -41.7% | Apr 4, 2024 |
| Mizuho Securities | Nitin Kumar | $160 | $128.38 | -58.9% | Mar 10, 2023 |
| UBS | Manav Gupta | $165 | $129.41 | -57.7% | Mar 9, 2023 |
| Cowen & Co. | Analyst unavailable | $143 | $123.85 | -63.3% | Feb 1, 2023 |
| Wells Fargo | Analyst unavailable | $153 | $125.67 | -60.7% | Feb 1, 2023 |
| Raymond James | Analyst unavailable | $165 | $128.52 | -57.7% | Feb 1, 2023 |
| Raymond James | Analyst unavailable | $155 | $122.08 | -60.2% | Jan 13, 2023 |
| Piper Sandler | Analyst unavailable | $143 | $109.75 | -63.3% | Dec 19, 2022 |
| Wells Fargo | Roger Read | $117 | $95.79 | -70.0% | Aug 16, 2022 |
| BMO Capital | Phillip Jungwirth | $135 | $84.48 | -65.4% | Jun 29, 2022 |
| Wells Fargo | Roger Read | $129 | $102.17 | -66.9% | Jun 14, 2022 |
| Credit Suisse | Analyst unavailable | $110 | $93.42 | -71.8% | May 4, 2022 |
| Citigroup | Analyst unavailable | $108 | $84.86 | -72.3% | Apr 26, 2022 |
| Morgan Stanley | Connor Lynagh | $115 | $84.08 | -70.5% | Apr 25, 2022 |
| Wells Fargo | Analyst unavailable | $110 | $90.98 | -71.8% | Apr 21, 2022 |
| Citigroup | Prashant Rao | $85 | $72.81 | -78.2% | Jan 19, 2022 |
| Barclays | Theresa Chen | $80 | $72.16 | -79.5% | Jan 11, 2022 |
| Bank of America Securities | Doug Leggate | $88 | $69.93 | -77.4% | Jan 10, 2022 |
| UBS | Lloyd Byrne | $73 | $63.11 | -81.3% | Nov 17, 2021 |
| Goldman Sachs | Neil Mehta | $73 | $62.66 | -81.3% | Nov 3, 2021 |
| Wolfe Research | Sam Margolin | $68 | $55.29 | -82.5% | May 4, 2021 |
Track every rating change on MPC the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationMarathon Petroleum Corporation (MPC) functions as a prominent integrated energy enterprise, primarily concentrating its downstream operations across the United States. Its business is bifurcated into two main divisions: Refining & Marketing, and Midstream. The Refining & Marketing segment is responsible for processing crude oil and various other raw materials at its refineries, strategically located in the U.S. Gulf Coast, Mid-Continent, and West Coast regions. This division also acquires refined petroleum products and ethanol for subsequent distribution. Key outputs from this segment encompass a diverse array of transportation fuels, including different gasoline blends, heavy fuel oil, and asphalt. Additionally, it manufactures chemicals such as aromatics, propane, propylene, and sulfur.…
Historical context
All MPC earningsLatest beats and misses
Who reports nextBeat on EPS
- SNXFY2026 Q3 · September 24, 2026+20.9% EPS-9.9% move
- DRIFY2027 Q1 · September 24, 20260.0% EPS-3.0% move
- CTASFY2027 Q1 · September 23, 2026+3.0% EPS-3.4% move
- PAYXFY2027 Q1 · September 23, 2026+1.5% EPS-8.8% move
- GISFY2027 Q1 · September 23, 2026+4.6% EPS+1.0% move
- AZOFY2026 Q4 · September 22, 2026+3.6% EPS+3.3% move
Get the MPC recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-09-25T17:00:58.506510+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-25T17:00:58.503795+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-25. For educational purposes only; not investment advice.